Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $72.00 Analyst target: $105.78 Upside: 46.92%
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
See the full interactive analysis & chart →Informational only — not investment advice.